Now showing items 1378-1397 of 6362

    • Cost analysis of large-scale implementation of the ‘Helping Babies Breathe’ newborn resuscitation-training program in Tanzania 

      Chaudhury, Sumona; Arlington, Lauren; Brenan, Shelby; Kairuki, Allan Kaijunga; Meda, Amunga Robson; Isangula, Kahabi G.; Mponzi, Victor; Bishanga, Dunstan; Thomas, Erica; Msemo, Georgina; Azayo, Mary; Molinier, Alice; Nelson, Brett Dee (Springer Nature, 2016)
      Background: Helping Babies Breathe (HBB) has become the gold standard globally for training birth-attendants in neonatal resuscitation in low-resource settings in efforts to reduce early newborn asphyxia and mortality. The ...
    • The cost of a primary care-based childhood obesity prevention intervention 

      Wright, Davene R; Taveras, Elsie M; Gillman, Matthew W; Horan, Christine M; Hohman, Katherine H; Gortmaker, Steven L; Prosser, Lisa A (BioMed Central, 2014)
      Background: United States pediatric guidelines recommend that childhood obesity counseling be conducted in the primary care setting. Primary care-based interventions can be effective in improving health behaviors, but also ...
    • The Cost of Low Fertility in Europe 

      Bloom, David E.; Canning, David J.; Fink, Gunther; Finlay, Jocelyn E. (Springer Science + Business Media, 2009)
      We analyze the effect of fertility on income per capita with a particular focus on the experience of Europe. For European countries with below-replacement fertility, the cost of continued low fertility will only be observed ...
    • Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly 

      McGarry, Lisa J.; Krishnarajah, Girishanthy; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Masseria, Cristina; Arondekar, Bhakti; Pelton, Stephen I.; Weinstein, Milton C. (Public Library of Science, 2013)
      Objectives: Health benefits and costs of combined reduced-antigen-content tetanus, diphtheria, and pertussis (Tdap) immunization among adults ≥65 years have not been evaluated. In February 2012, the Advisory Committee on ...
    • Cost-effectiveness of alternative blood-screening strategies for West Nile virus in the United States 

      Korves, Caroline T; Goldie, Sue J.; Murray, Megan Blanche (Public Library of Science, 2006)
      Background: West Nile virus (WNV) is endemic in the US, varying seasonally and by geographic region. WNV can be transmitted by blood transfusion, and mandatory screening of blood for WNV was recently introduced throughout ...
    • Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway 

      Burger, E A; Ortendahl, J; Sy, Stephen; Kristiansen, I S; Kim, Jane Jooyun (Nature Publishing Group, 2012)
      Background: New screening technologies and vaccination against human papillomavirus (HPV), the necessary cause of cervical cancer, may impact optimal approaches to prevent cervical cancer. We evaluated the cost-effectiveness ...
    • The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women 

      McCabe, Caitlin J.; Goldie, Sue J.; Fisman, David N.; Loutfy, Mona Rafik (Public Library of Science, 2010)
      Background: In HIV-infected pregnant women, viral suppression prevents mother-to-child HIV transmission. Directly observed highly-active antiretroviral therapy (HAART) enhances virological suppression, and could prevent ...
    • Cost-Effectiveness of Early Infant HIV Diagnosis of HIV-Exposed Infants and Immediate Antiretroviral Therapy in HIV-Infected Children under 24 Months in Thailand 

      Collins, Intira Jeannie; Cairns, John; Ngo-Giang-Huong, Nicole; Sirirungsi, Wasna; Leechanachai, Pranee; Le Coeur, Sophie; Samleerat, Tanawan; Kamonpakorn, Nareerat; Mekmullica, Jutarat; Jourdain, Gonzague; Lallemant, Marc (Public Library of Science, 2014)
      Background: HIV-infected infants have high risk of death in the first two years of life if untreated. WHO guidelines recommend early infant HIV diagnosis (EID) of all HIV-exposed infants and immediate antiretroviral therapy ...
    • Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age 

      Ciaranello, Andrea L.; Doherty, Kathleen; Penazzato, Martina; Lindsey, Jane C.; Harrison, Linda; Kelly, Kathleen; Walensky, Rochelle P.; Essajee, Shaffiq; Losina, Elena; Muhe, Lulu; Wools-Kaloustian, Kara; Ayaya, Samuel; Weinstein, Milton C.; Palumbo, Paul; Freedberg, Kenneth A. (Lippincott Williams & Wilkins, 2015)
      Background: The International Maternal, Pediatric, and Adolescent Clinical Trials P1060 trial demonstrated superior outcomes for HIV-infected children less than 3 years old initiating antiretroviral therapy (ART) with ...
    • Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil 

      Luz, Paula M.; Morris, Bethany L.; Grinsztejn, Beatriz; Freedberg, Kenneth A.; Veloso, Valdilea G.; Walensky, Rochelle P.; Losina, Elena; Nakamura, Yoriko M.; Girouard, Michael P.; Sax, Paul E.; Struchiner, Claudio J.; Paltiel, A. David (JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014)
      Objective: HIV genotype-resistance testing can help identify more effective antiretroviral treatment (ART) regimens for patients, substantially increasing the likelihood of viral suppression and immune recovery. We sought ...
    • Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India 

      Uhler, Lauren M.; Kumarasamy, Nagalingeswaran; Saxena, Anjali; Muniyandi, Malaisamy; Stoler, Adam W.; Lu, Zhigang; Flanigan, Timothy P.; Bender, Melissa A.; Swaminathan, Soumya; Mayer, Kenneth H.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth Alan; Swaminathan, Soumya (Public Library of Science, 2010)
      Background: Indian guidelines recommend routine referral for HIV testing of all tuberculosis (TB) patients in the nine states with the highest HIV prevalence, and selective referral for testing elsewhere. We assessed the ...
    • Cost-Effectiveness of New Cardiac and Vascular Rehabilitation Strategies for Patients with Coronary Artery Disease 

      Spronk, Sandra; Bosch, Johanna L.; Ryjewski, Constance; Rosenblum, Judith; Kaandorp, Guido C.; White, John V.; Hunink, Maria G M (Public Library of Science, 2008)
      Objective: Peripheral arterial disease (PAD) often hinders the cardiac rehabilitation program. The aim of this study was evaluating the relative cost-effectiveness of new rehabilitation strategies which include the diagnosis ...
    • Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal 

      Touré, Hapsatou; Uhler, Lauren M.; Anglaret, Xavier; Paltiel, A. David; Balestre, Eric; Messou, Eugène; Dabis, François; Losina, Elena; Walensky, Rochelle P.; Weinstein, Milton C.; Freedberg, Kenneth Alan (Public Library of Science, 2009)
      Background: Data from HIV treatment programs in resource-limited settings show extensive rates of loss to follow-up (LTFU) ranging from 5% to 40% within 6 mo of antiretroviral therapy (ART) initiation. Our objective was ...
    • Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective 

      Smith, Emily Rose; Rowlinson, Emily E.; Iniguez, Volga; Etienne, Kizee A.; Rivera, Rosario; Mamani, Nataniel; Rheingans, Rick; Patzi, Maritza; Halkyer, Percy; Leon, Juan S. (Elsevier BV, 2011)
      BACKGROUND—In Bolivia, in 2008, the under-five mortality rate is 54 per 1000 live births. Diarrhea causes 15% of these deaths, and 40% of pediatric diarrhea-related hospitalizations are caused by rotavirus illness (RI). ...
    • Cost-Effectiveness of Rotavirus Vaccination in Vietnam 

      Kim, Sun-Young; Goldie, Sue J.; Salomon, Joshua A. (BioMed Central, 2009)
      Background: Rotavirus is the most common cause of severe diarrhea leading to hospitalization or disease-specific death among young children. New rotavirus vaccines have recently been approved. Some previous studies have ...
    • Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission 

      McGarry, Lisa J.; Krishnarajah, Girishanthy; Hill, Gregory; Masseria, Cristina; Skornicki, Michelle; Pruttivarasin, Narin; Arondekar, Bhakti; Roiz, Julie; Pelton, Stephen I.; Weinstein, Milton C. (Public Library of Science, 2014)
      Objectives: In February 2012, the Advisory Committee on Immunization Practices (ACIP) advised that all adults aged ≥65 years receive a single dose of reduced-antigen-content tetanus, diphtheria, and acellular pertussis ...
    • Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis 

      Resch, Stephen C; Salomon, Joshua A.; Murray, Megan Blanche; Weinstein, Milton C. (Public Library of Science, 2006)
      Background: Despite the existence of effective drug treatments, tuberculosis (TB) causes 2 million deaths annually worldwide. Effective treatment is complicated by multidrug-resistant TB (MDR TB) strains that respond only ...
    • The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis 

      Pho, Mai T.; Swaminathan, Soumya; Kumarasamy, Nagalingeswaran; Losina, Elena; Ponnuraja, C.; Uhler, Lauren M.; Scott, Callie A.; Mayer, Kenneth Hugh; Freedberg, Kenneth Alan; Walensky, Rochelle P. (Public Library of Science, 2012)
      Background: Regimens for isoniazid-based preventive therapy (IPT) for tuberculosis (TB) in HIV-infected individuals have not been widely adopted given concerns regarding efficacy, adherence and drug resistance. Further, ...
    • Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries 

      Kiatpongsan, Sorapop; Kim, Jane J. (Public Library of Science, 2014)
      Background: Current prophylactic vaccines against human papillomavirus (HPV) target two of the most oncogenic types, HPV-16 and -18, which contribute to roughly 70% of cervical cancers worldwide. Second-generation HPV ...
    • The Costs of Adverse Drug Events in Hospitalized Patients 

      Bates, David; Spell, Nathan; Cullen, David J.; Burdick, Elisabeth; Laird, Nan; Petersen, Laura A.; Small, Stephen D.; Sweitzer, Bobbie J.; Leape, Lucian (American Medical Association (AMA), 1997-01-22)
      Objective: To assess the additional resource utilization associated with an adverse drug event (ADE). Design: Nested case-control study within a prospective cohort study. Participants: The cohort included 4108 ...